Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Randomized, Double-blind, Placebo-controlled Trial, Followed by Single-arm Treatment of PRO 140 in Combination With Optimized Background Therapy in Treatment-Experienced HIV-1 Subjects

NCT02483078 is registered in ClinicalTrials.gov with CytoDyn, Inc. as lead sponsor.

NCT NCT02483078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02483078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Randomized, Double-blind, Placebo-controlled Trial, Followed by Single-arm Treatment of PRO 140 in Combination With Optimized Background Therapy in Treatment-Experienced HIV-1 Subjects
Lead sponsor
CytoDyn, Inc.
Phase
Phase 2/3
Overall status
Completed
Start date
October 31, 2015
Completion date
July 31, 2018
Enrollment
52 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

hiv